Syndicated Science™ Insights
Transform insights into action to support your real-world evidence strategies
Discover Hidden Hypotheses with Our Turnkey
Analytical Solutions
Harnessing the power of our causalPHR™ visualization platform, Target RWE has created turnkey reports providing an anthology of research throughout the drug development life cycle, called Syndicated Science™ Insights (SSI). Our SSI solutions contain rich scientific content and are brought to life through interactive visualizations on our easy-to-access web-based platform. Each report contains deep filtering and stratification capabilities enabling the exploration of patient subgroups of interest by phenotype, social demographics, insurance type, comorbidities, and much more.
We offer two types of SSI reports, catering to the choice of data source, clinical area, and types of evidence needed: Community Insights and Market Insights.
Community Insights
Explore our proprietary data through our dynamic, turnkey reports that extract deep insights from Target RWE registries, using advanced statistical and epidemiological methods.
-
Structured and unstructured data show patient journey in line with standard of care
-
Disease-relevant cohorts enable deeper insights, with narrow analyses on patient labs, PROs, and biosamples
-
Extract insights typically hidden within physician notes, including common labs, tests, characteristics by first line, and most common procedures
Stratify Community Insights by Phenotype,
Social Demographics, Insurance Type, Comorbidities, and More
Patient Measures
- Common patient-reported outcome (PRO) measures, such as PROMIS
- Common labs, tests, standards of care
- Median values of PROMIS, PRO measures and variation following therapy changes
Treatments
- Characteristics and factors associated with initiating treatments
- Variation of treatment regimens across subgroups and length of treatment
- Progression of patient management
- Time to progression to endpoints of interest
Procedures & Progression
- Cumulative incidence and frequency of tests, procedures, and progression across disease states
- Scoring systems to evaluate disease
- Survival estimates and variation
- Unadjusted associations between baseline risk factors and outcomes
Market Insights
Learn about a disease state through our dynamic, turnkey reports that extract deep insights from large claims datasets, using advanced statistical and epidemiological methods.
-
Estimate prevalence and incidence in an affected population
-
Inform hypotheses by stratification of variables of interest
-
Serve as an anthology of research for internal & external reporting
-
Insights include demographics and clinical characteristics, incidence/prevalence of disease, patterns of treatment over time, and risk of an outcome
Investigate Large Patient Populations
and Treatments of Interest Over Time with Market Insights
Population Characteristics
- Distribution of demographics and clinical characteristics in the source population
- Trends in comorbidities over time across subgroups
Incidence & Prevalence
- Incidence and prevalence of disease, variation across subgroups and comorbidities
- Distributions of socioeconomic and clinical characteristics
- Geographic variations in incidence and prevalence
Treatments
- Patterns of treatment over time
- Likelihood of starting a specific medication by a certain time point following diagnosis, across subgroups
- Variation of starting a medication at a certain time point with presence of a comorbidity
Outcomes
- Risk of an outcome following a new diagnosis and variation across subgroups
- Timing of an outcome occurring following a new diagnosis
- Likelihood to experience an outcome based on comorbidities
Analytics Built for a Deeper Understanding of Real-World Data
Rigorous: Target RWE builds analytical content using robust, cutting-edge epidemiologic and statistical methods
Peer Review & Publication Friendly: Each SSI solution supports a full peer review workflow with all methods clearly stated and provided with content, facilitating easy communication and public dissemination
Deeply Interactive: All SSI content can be layered and explored by users for subgroup analyses. Visualizations, graphs, and tables can be stratified and filtered across patient, provider, and region-level characteristics
Timely: All content can be easily refreshed with updated data
Comprehensive: Each SSI solution contains content relevant to all phases of a product’s life cycle, including forecasting to assess the size of addressable populations, descriptive analysis of contemporary treatment patterns, identification of high-risk patient subgroups, trend monitoring for policy evaluation, and causal inference for principled safety and effectiveness research
